Gilead Sciences' (GILD) Antiviral Drug Remdesivir Flops in First trial - FT
Go back to Gilead Sciences' (GILD) Antiviral Drug Remdesivir Flops in First trial - FT| Gilead Sciences (NASDAQ: GILD) | Delayed: 124.86 +1.10 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.76 | 52 Week High | $108.63 | |||
| Open | $124.30 | 52 Week Low | $71.39 | |||
| Day High | $125.17 | P/E | 68.98 | |||
| Day Low | $123.00 | EPS | $1.81 | |||
| Volume | 4,604,518 | |||||
| S&P DEP RECEIPTS (NYSE: SPY) | Delayed: 743.85 -2.89 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $746.74 | 52 Week High | $219.60 | |||
| Open | $747.70 | 52 Week Low | $181.02 | |||
| Day High | $750.18 | P/E | N/A | |||
| Day Low | $743.13 | EPS | $0.00 | |||
| Volume | 34,726,493 | |||||
